American Journal of Medicine and Medical Sciences
p-ISSN: 2165-901X e-ISSN: 2165-9036
2018; 8(9): 219-225
doi:10.5923/j.ajmms.20180809.01
Mona Abd EL Rahman Eldosoky 1, Amany M. Abdallah 2, Noha Abdel-Rahman Eldesoky 3, Maha A. Hassan 2, Gihan A. Eldesoky 4
1Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Egypt
2Internal Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Egypt
3Biochemistry Department, Faculty of Pharmacy for Girls, Al-Azhar University, Egypt
4Anesthesia and Intensive Care Department, Faculty of Medicine for Girls, Al-Azhar University, Egypt
Correspondence to: Noha Abdel-Rahman Eldesoky , Biochemistry Department, Faculty of Pharmacy for Girls, Al-Azhar University, Egypt.
Email: |
Copyright © 2018 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Background: Type 2 Diabetes Mellitus (T2DM), is a global public health crisis that threatens the economies of all nations, particularly developing countries. Cardiovascular complications are the main cause of mortality in T2DM patients. Objective: The aim of this study is to explore the role of acute-phase proteins (Orsomucoid 2 and hs-CRP) as predictors for subclinical atherosclerosis and their relation with dyslipidaemia and Carotid intima media thicknes (CIMT) in lean T2DM patients. Methods: 50 diabetic normal weight patients (22 males and 28 females) were recruited from internal medicine department, AL-Zahraa hospital and divided into two groups: Group 1; twenty five type 2 diabetics with increased CIMT (≥ 0.9 mm) and Group 2; twenty five diabetic patients with normal CIMT (<0.9 mm). All the participants were subjected to full medical history, full clinical examination, and routine Laboratory investigations: Serum fasting glucose, urea, creatinine, uric acid, potassium, calcium, phosphorous, bilirubin, ALT, AST, albumin, complete lipid profile, hs-CRP and Orsomucoid 2 (ORM2) assay. Electrocardiogram (ECG), Echocardiography and B-mode ultrasonography of left and right carotid arteries were also assessed. Findings: Serum orsomucoid 2 and hs-crp were significantly higher in group 1 compared to group 2 at (p≤0.001). Serum orosomucoid 2 at cut off 11.05 ng/L could discriminate patients with and without subclinical atherosclerosis. There was Positive correlation between serum orsomucoid level, hs-CRP and each of CIMT, LDL-C, and TG while negative correlation was found with HDL-C. Mean CIMT presented positive correlation with total cholesterol level, triglycerides and low-density lipoprotein. Conclusions: Our findings suggest that orsomucoid 2 and hs-CRP could be used effectively as biomarkers for subclinical atherosclerosis in lean T2DM patients.
Keywords: Carotid intima media thickness, Diabetes mellitus, Atherosclerosis, Orsomucoid, hs-CRP
Cite this paper: Mona Abd EL Rahman Eldosoky , Amany M. Abdallah , Noha Abdel-Rahman Eldesoky , Maha A. Hassan , Gihan A. Eldesoky , Role of Acute-phase Proteins (Orsomucoid 2 and hs-CRP) in Lean Type 2 Diabetic Patients with and without Subclinical Atherosclerosis, American Journal of Medicine and Medical Sciences, Vol. 8 No. 9, 2018, pp. 219-225. doi: 10.5923/j.ajmms.20180809.01.
|
Figure 1. Orsomucoid 2 and hs-CRP were significantly higher in diabetics with high CIMT |
|
Figure 2. Correlation between orsomucoid 2 level and mean CIMT in all diabetic patients |
Figure 3. Correlation between Orsomucoid 2 and LDL cholesterol in all diabetic patients |
Figure 4. Correlation between orsomucoid 2 and HDL cholesterol in all studied diabetic patients |
|
Figure 5. ROC curve showing the diagnostic performance of orsomucoid 2 and hs-CRP for discriminating diabetic patients with subclinical atherosclerosis |